May 2026

Job as Operators / Chemists at Sri Krishna Pharmaceuticals | B.Sc / M.Sc / B.Pharm / M.Pharm / Diploma / ITI can apply

28 May 2026

Job as Operators / Staff at Sri Krishna Pharmaceuticals | B.Sc / M.Sc / B.Pharm / M.Pharm / Diploma / ITI can apply

B.Sc / M.Sc / B.Pharm / M.Pharm. Experience in Pharmaceutical Manufacturing. Knowledge of GMP & cGMP guidelines. Handling Granulation & Compression Machines

28 May 2026

Amgen Hiring Central Monitor Manager, Data Acquisition Lead, Data Delivery Lead

Lead proactive, data-driven risk surveillance across studies using central monitoring analytics to detect trends, anomalies, and emerging risks.

28 May 2026

Work as Pharmacovigilance Services Analyst at Accenture

Your day to day interaction is with peers within Accenture before updating supervisors. In this role you may have limited exposure with clients and/or Accenture management.

28 May 2026

Hiring for Analytical Development Laboratory at APDM Pharma

Responsible for analytical method development, method validation and analytical support activities using Gas Chromatography techniques for oral solid dosage formulations.

28 May 2026

Hiring for Production Department (Packing & Filling) at Encube Ethicals

Encube Ethicals Pvt Ltd, Pithampur (M.P.) is looking for passionate and experienced professionals to join our Production Team.

28 May 2026

Quality Control and Quality Assurance Jobs at SBL Private Limited

SBL stands as the premier manufacturer ot homoeopathic medicines in India, providing an extensive array ot top-notch homeopathic solution.

28 May 2026

Apply Online for Clinical Trial Manager at ICON plc

Plan and manage all aspects of clinical trials, ensuring adherence to timelines, budget, and quality standards.

28 May 2026

CDSCO Approves Wockhardt’s Breakthrough Antibiotic ZAYNICH® for Complicated Urinary Tract Infections

Wockhardt has received marketing authorization from India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), for its breakthrough antibiotic ZAYNICH® (Zidebactam/Cefepime). The approval marks a significant milestone for India’s fight against antimicrobial resistance, especially in difficult-to-treat Gram-negative bacterial infections.

28 May 2026

Sun Pharma to Present Long-Term UNLOXCYT Data at ASCO 2026

Mumbai-based Sun Pharmaceutical Industries Limited has announced that it will present updated long-term clinical data for UNLOXCYT™ (cosibelimab-ipdl) at the upcoming ASCO Annual Meeting in Chicago. The presentation will focus on patients suffering from locally advanced cutaneous squamous cell carcinoma (laCSCC), a serious form of skin cancer.